The Team

As a transatlantic partnership, the Oxford-Harrington Rare Disease Centre (OHC) is supported by teams in Oxford and Cleveland, led by Director and Chief Scientific Officer Professor Matthew Wood.

Matthew Wood, MD, PhD

Matthew Wood, MD, PhD

Director & Chief Scientific Officer

Matthew Anderson, MD, PhD

Matthew Anderson, MD, PhD

Co-Director

Georg Holländer, MD, PhD

Georg Holländer, MD, PhD

Head of Department, Oxford Department of Paediatrics

Carlo Rinaldi, MD, PhD

Carlo Rinaldi, MD, PhD

Professor of Molecular and Translational Neuroscience

Geoffrey Denwood, PhD

Geoffrey Denwood, PhD

Research Facilitator

Paige Fillier

Paige Fillier

Deputy Head of Development

Louise Gillane

Louise Gillane

Administrator

Tyrone Gorden

Tyrone Gorden

Vice President of Global Development

Katie Harris

Katie Harris

Program and Brand Manager

Rufina Kaloyanova

Rufina Kaloyanova

Communications Manager

Becca Koopman

Becca Koopman

Project Manager Associate of Programs

Bronwyn Monroe, MBA

Bronwyn Monroe, MBA

Program Director

Mohammad Osman, MBA

Mohammad Osman, MBA

Program Manager

Julie Stevens, PhD

Julie Stevens, PhD

Director of Operations

Julie Woda, PhD

Julie Woda, PhD

Vice President of Therapeutics Development

Advisory Council

The Advisory Council supports the OHC in its philanthropic mission, builds partnership, expertise and networks, and builds global awareness of the OHC and its aims.

Lord Cameron

Lord Cameron

Chair

Sir John Bell

Sir John Bell

Professor Emeritus, University of Oxford

Baroness Nicola Blackwood

Baroness Nicola Blackwood

Chair of Oxford University Innovation and Genomics England

John Crowley

John Crowley

CEO, Biotechnology Innovation Organization (BIO)

Ron Harrington

Ron Harrington

Entrepreneur and Philanthropist

Majid Jafar

Majid Jafar

Co-founder of the Loulou Foundation

Jonathan Stamler, MD

Jonathan Stamler, MD

President and co-Founder of Harrington Discovery Institute